SUMMARY JC virus was previously isolated from the urine and from diseased brain of a patient with progressive multifocal leukoencephalopathy. The DNAs of these isolates, MAD-7 and MAD-8 respectively, were shown in this study to be mixtures of several different full-length genomes. By differences in their restriction endonuclease cleavage patterns, the genomes were categorized into two types. Type I DNA was defined as that typified by the prototype virus, MAD-l; Type II, that typified by viral DNA molecularly cloned from brain tissue of the MAD-7/8 patient (BrC-8 DNA). MAD-7 DNA was an approximately equal mixture of Type I and Type II; MAD-8 DNA appeared to be homogeneously Type II. These DNAs were molecularly cloned for further studies. Of 17 clones of recombinant MAD-7 (rMAD-7) DNA, nine were Type I and were identical to each other and to MAD-1 DNA. The other eight clones comprised five different species of Type II, none of which was identical to MAD-8 or to BrC-8 DNA. Among 17 recombinant MAD-8 (rMAD-8) clones there were two which contained Type I DNA, which had not been detected in the original viral DNA. The remaining rMAD-8 clones were of Type II. The differences among all these DNAs were primarily in the 'extra' PvulI sites and in the insertions and deletions in the hypervariable regulatory region of the genome (0-67 to 0.72 map unit). Possible explanations for multiple genomes in separate isolates from the same patient are discussed. It is concluded that the observed variation originated in vivo and not during isolation in vitro.
The human polyomavirus JC (JCV) is regularly associated with the lesions in brains of persons who have succumbed to the slowly demyelinative disease progressive multifocal leukoencephalopathy Walker, 1978; Padgett & Walker, 1983) . Isolates of JCV have been obtained by cultivation of independent brain homogenates through a few passages at low multiplicities of infection in primary cultures of human foetal glial cells (Padgett et al., 1971 Grinnell et al., 1982) . The genomes of 14 isolates differ from each other in their restriction endonuclease cleavage patterns, demonstrated with viral DNAs prepared from infected cells (Grinnell et al., 1983a; J. Martin, unpublished observations) and molecularly cloned from diseased brains (Rentier-Delrue et al., 1981 ; Grinnetl et al., 1983b) . Variation is localized primarily, but not exclusively, in the region 0.67 to 0.72 map unit (m.u.) as defined for prototype (MAD-l) DNA. This region includes the origin of replication and presumptive regulatory sequences (Law et al., 1979; Frisque, 1983; Grinnell et al., 1983b; Miyamura et al., 1983) . The hypervariability of this region is reflected by 'extra' PvuII sites and short deletions and insertions.
Isolates of the related polyomaviruses BK of humans and SV40 of rhesus monkeys also have regulatory regions which differ from one another (Reddy et al., 1978; van Heuverswyn & Fiers, 1979; Yang & Wu, 1979) . Ruley & Fried (1983) have found that no two of several polyoma virus isolates have identical regulatory regions. Although hypervariability of an important control region might be unexpected, it appears to be a regular feature of the polyomavirus group. The origin of this hypervariability is not known. There may he many natural, genetically stable strains of polyomaviruses which circulate, or there may be only one or a very few unstable 0022-1317/84/0000-6040 $02.00 © 1984 SGM Fig. 1 . Type 1 JCV DNA of MAD-7 and Type II DNAs of MAD-7 and MAD-8. Viral DNAs were prepared from infected cultures of human foetal glial cells. Portions (0.5 ~tg) were digested with PvulI or with Hincll, and the products were analysed by agarose gel electrophoresis. After eight passages at multiplicities less than 0-1 infectious unit/cell, prototype (MAD-l) and MAD-2 DNAs were heterogeneous in size ; three Pvull and four Hincll fragments define the full-length genome , which is designated Type I. At three passages, MAD-8 DNA was homogeneously full length and contained additional PvulI and HinclI sites; the genome is designated Type II. PvulI fragment A3 of MAD-8 was run off the gel. The uncleaved DNA of MAD-7 (passage 4) was homogeneously full length (not shown). The MAD-7 digests shown here suggest equal portions of both Type I and Type II genomes. (Fragments marked here by dashes were clearly visible in the original photograph.)
strains. In the latter case the observed variety of isolates may be a consequence of rapid evolution of the viral genome during latency, reactivation, and/or the course of disease in the natural host. In the case of the human polyomaviruses, the viruses isolated from different patients have different regulatory regions (Grinnell et al., 1983 b; Rentier-Delrue et al., 1981 ; Seif et al., 1979; Yang & Wu, 1979) . A unique opportunity to study variation in JCV occurred when virus was isolated from urine (MAD-7) and from the brain (MAD-8) of the same patient (Rand et al., 1977; Grinnell et al., 1982) . In a previous study , the viral D N A (Br-8) purified directly from the brain of the MAD-7/8 patient was homogeneous in size and was full length. Whether or not the Br-8 D N A was homogeneous genetically is not clear. A molecular recombinant of the D N A was logically presumed to be representative of the Br-8 D N A , and it was characterized by restriction endonuclease cleavage analysis as a particular type of variant (Grinnell et al., 1983 b) . We report here that the D N A of MAD-7 is composed of equal amounts of prototype (Type I) D N A and several species of D N A of the general type (Type II) represented by Br-8 D N A . In contrast, the majority of MAD-8 D N A was of one species (Type II), but prototype (Type I) D N A was detectable, also. The differences among MAD-7 and MAD-8 Type II D N A s were mapped in the hypervariable regulatory region of the genome. These observations are strongly suggestive of genetic instability in the genome of JCV during its infection of the host.
Isolations of JCV MAD-7 and MAD-8 from a 46-year-old male with chronic lymphocytic leukaemia have been described previously (Rand et al., 1977; Grinnell et al., 1982) . Because original specimens were no longer available, primary human foetal glial cells infected with these isolates were graciously provided by B. L. Padgett and D. L. Walker (University of Wisconsin Medical School, Madison, Wis., U.S.A.). The infected cells represented the fourth (MAD-7) and the third (MAD-8) passages of the viruses at multiplicities of infection less than 0.1 infectious unit/cell. Virus-specific DNAs were purified from lysates of frozen infected-ceU pellets (Hirt, 1967) by two consecutive equilibrium centrifugations in CsCl-ethidium bromide solution.
Unlike the typically heterogeneous DNA of prototype (MAD-l) virus, the DNAs of MAD-7 and -8 were homogeneous in size (Grinnell et al., 1983a) . Both EcoRI and BamHI linearized the viral DNAs, and the linear molecules migrated in electrophoretic gels as single, full-length bands (gel not shown). With respect to prototype (Type I) DNA (MAD-1 and -2; Fig. 1 a, b, Frisque, 1983) . The extra HindII site is at 0.89 m.u., in the VP2/3 codons (Law et al., 1979) . The respective sets of fragments each constituted the full-length genome and in these respects MAD-8 DNA was identical to DNA cloned directly from brain tissue of the patient (Grinnell et al., 1983 b) . Thus, MAD-8 DNA appeared to be homogeneously Type II. In surprising contrast MAD-7 DNA contained both the prototypical PvuII fragment A and the variant subfragments A1 and A2" (Fig. 1 c) . MAD-7 DNA also had both the prototypical HincII fragment D and the variant subfragments D 1 and D2 (lane g). The sum of fragment sizes in each set was too large to be a single full-length genome. Visual inspection and densitometric tracings of photographic negatives suggested that MAD-7 PvuII fragments B and C and HincII fragments A, B and C were in molar excess of the remaining fragments. It was concluded that MAD-7 DNA consisted of approximately equal proportions of two full-length genomes: one of Type I DNA and one of Type II, each having apparent identity with MAD-1 and MAD-8 DNAs, respectively. Molecular cloning experiments described below support this conclusion but identify additional complexities.
MAD-7 and MAD-8 DNAs were cloned at their unique EcoRI cleavage sites in pBR322 essentially as described by others (Israel et al., 1979; Grinnell et al., 1983b) . For each isolate, recombinants having apparently full-length inserts were analysed by PvuII and HincII cleavage for the type of JCV genome present. A recombinant (BrC-1) of viral DNA purified from diseased brain tissue of the MAD-1 patient was used as a reference DNA (Grinnell et al., 1983 b; Martin et al., 1982) . Of the 17 MAD-7 clones (rMAD-7) that were screened, nine were identified as Type I, and eight as Type II (gels not shown). These clones were therefore representative of the dual genome of the original MAD-7 viral DNA (Fig. 1) . Similar analyses of the 17 MAD-8 recombinants (rMAD-8) for genome type indicated that 15 were of Type II (gels not shown). This result was anticipated because visual inspection of electrophoretic gels of the original MAD-8 viral DNA suggested that it was homogeneously Type II (Fig. 1) . Indeed, a clone of MAD-8 DNA (BrC-8) derived from diseased brain tissue was Type II (Grinnell et al., 1983b ). An unexpected result, however, was that two of the rMAD-8 clones had a Type I JCV DNA insert. Thus, the original MAD-8 viral DNA in fact was heterogeneous in genome type, although the Type I DNA was a minor component.
In agarose gels (not shown) it was noted that the Type II DNA of rMAD-7 was slightly different from that of rMAD-8, even though the viruses were isolated from the same patient. Therefore, the Type II DNA restriction fragments produced by PvuII were analysed in acrylamide gels. Type I DNAs were analysed also, but were found to be identical (gels not shown). PvuII analyses were done singly and in combination with HindIII. The double digestions were useful because they produced a fragment [261 _+ 6 bp (n = 5) in Type I; 0-67 to 0.716 m.u. ] that contained the extra PvuII sites characteristic of Type II DNA. Fig. 2 shows the 261 bp diagnostic fragment in DNA cloned directly from brain tissue of the prototype patient (BrC-1 DNA). Representative Type II rMAD-7 DNAs (7D and 7E), which had (Frisque, 1983) , migrated anomalously ir. acrylamide gels as 220 bp. appeared to be identical in agarose gels, clearly differed in the diagnostic region. Compared with BrC-1, each had a single additional PvulI site in the 261 bp fragment, but it was located differently in each. The sum of the two rMAD-7E fragments, 303 +_ 4 bp (n = 3), indicates an insertion of 42 bp. Unlike 7E, r M A D -7 D contained a deletion of 38 bp, the region being 223 _ 2 bp (n = 3) in length. Table 1 indicates the variety in the extra PvulI sites of the eight rMAD-7 clones that were Type II. The 0-67 to 0.72 region of the majority of these clones was 222 to 275 bp in length and contained only one extra PvulI site. Both r M A D -8 A A and -8BB contained the same two extra PvulI sites (Fig. 2) , as did 13 other clones (Table 1 ). The sum of the three fragments, 297 _ 4 bp (n = 6), implies that there is an insertion of 36 bp within the region. None of the Type II D N A s produced by JCV isolated from urine (MAD-7) was identical to the Type II genomes of virus isolated from brain (MAD-8) of the same patient (Table 1) .
There are at least four explanations for the mixed population of MAD-7 and -8 D N A s and their differences from D N A (BrC-8) cloned from brain tissue of the patient. First, ~he differences were noted in recombinant D N A s and therefore could have been artefacts of molecular cloning. We have not noted any changes in restriction endonuclease cleavage patterns of Type I or Type II recombinants continually subcultured (in broth) ten times during a period of 5 days (data not shown). The D N A s described in this work were prepared from broth cultures inoculated with bacterial transformants 'passed' twice on agar plates. Thus, there was not Type A second explanation is the theoretical possibility that MAD-7 and, to a lesser extent, MAD-8 were contaminated with MAD-1 during isolation and propagation. This is most unlikely in view of the virological precautions employed in the laboratory in which the viruses were isolated and in view of the discontinuity of the passage histories of the isolates (Padgett et al., 1971 ; Rand et al., 1977; Grinnell et al., 1982) . Furthermore, it is doubtful that MAD-1 virus could accidentally and successfully contaminate cultures infected with MAD-7 and -8 such that MAD-1 DNA was replicated equally in one case (MAD-7) but quite unequally in the other .
A third explanation is that the various genomes of MAD-7 and MAD-8 DNAs evolved during propagation in vitro. If this explanation is correct, then genomes different from that in the original brain (DNA in urine could not be examined) evolved and became predominant in three to four low-multiplicity passages. There is precedence for tissue culture-induced changes in human polyomavirus DNA (Pater et al., 1981 ; Watanabe & Yoshiike, 1982; Grinnell et al., 1983a) . Alterations in SV40 and BK virus occur upon low-multiplicity passage in glial cells , but these alterations result in defective DNAs having repetitions of the origin of replication. However, the differences among the JCV MAD-7 and -8 DNA species do not involve simple repetitions of the origin of replication. Rather, there are sequence alterations upstream of the origin. Nucleotide sequencing data show that the alterations observed in rMAD-7D and rMAD-8AA (and in DNAs of five other MAD isolates) in fact occur in the 98-bp repeat region (Frisque, 1983) , are quite complex, and do not involve repetitions of the origin (J. Martin & R. Frisque, unpublished results) . Furthermore, both rMAD-7D and -8AA (Type II genomes) diverge from prototype MAD-1 DNA (Type I) at precisely the same point. Thus, the alterations are not random events. In view of these observations one cannot conclude that the multiple genomes of MAD-7 and -8 DNAs were strictly artefacts of tissue culture passage. In fact, the known sequence of full-length MAD-1 DNA, from 0.58 to 0.73 m.u., was not altered during eight passages in vitro; rMAD-1 and BrC-1 sequences are identical (Frisque, 1983) .
The fourth explanation is the most probable: multiple species of JCV DNA were present in the MAD-7/8 patient himself (Rand et al., 1977; Grinnell et al., 1982) . Multiple infection with a Type I and Type II virus could have occurred during the immunological naivet6 of childhood or during immunosuppressive therapy for leukaemia. One consequence of either of these events would be that both viruses established an infection of some
